ArticleTargeted oncology2023

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).

Estelle Dhamelincourt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.